THE EFFECTS OF DRONABINOL DURING DETOXIFICATION AND THE INITIATION OF TREATMENT WITH EXTENDED RELEASE NALTREXONE

BACKGROUND: Evidence suggests that the cannabinoid system is involved in the maintenance of opioid dependence. We examined whether dronabinol, a cannabinoid receptor type 1 partial agonist, reduces opioid withdrawal and increases retention in treatment with extended release naltrexone (XR-naltrexone...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Drug Alcohol Depend
Main Authors: Bisaga, Adam, Sullivan, Maria A., Glass, Andrew, Mishlen, Kaitlyn, Pavlicova, Martina, Haney, Margaret, Raby, Wilfrid N., Levin, Frances R., Carpenter, Kenneth M., Mariani, John J., Nunes, Edward V.
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4536087/
https://ncbi.nlm.nih.gov/pubmed/26187456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2015.05.013
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares